Key evidence highlights improvements in drug design through advancements in AI, particularly in peptide stability.
Generative AI facilitates innovative drug design, focusing on enhancing peptide stability and specificity.
Findings suggest that AI's role in peptide-based drug design may lead to more effective clinical treatments.
Abstract
Advances in AI-driven peptide design are accelerating the discovery of peptide-based drugs with enhanced stability, specificity, and clinical potential.